谷歌浏览器插件
订阅小程序
在清言上使用

495Tip A Phase II Study Evaluating the Safety and Efficacy of ENV-101 (taladegib) in Patients with Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

J. J. Luke, S. Pendyala,A. Di Francesco, S. Kim, L. Dellamary,H. Humphreys, M. De Los Rios, J. Pitman,J. Hood,D. S. Hong

Annals of Oncology(2022)

引用 0|浏览24
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要